2929 — Pharma Foods International Co Balance Sheet
0.000.00%
- ¥23bn
- ¥27bn
- ¥65bn
- 84
- 57
- 35
- 65
Annual balance sheet for Pharma Foods International Co, fiscal year end - July 31st, JPY millions except per share, conversion factor applied.
2021 July 31st | 2022 July 31st | 2023 July 31st | 2024 July 31st | 2025 July 31st | |
|---|---|---|---|---|---|
| Period Length: | — | — | — | — | — |
| Source: | Yuho | Yuho | Yuho | Yuho | Yuho |
| Standards: | JAS | JAS | JAS | JAS | JAS |
| Status: | Final | Final | Final | Final | Final |
| Cash and Equivalents | |||||
| Cash and Short Term Investments | 9,794 | 8,845 | 16,306 | 15,666 | 9,157 |
| Net Total Accounts Receivable | |||||
| Net Total Receivables | 4,917 | 7,425 | 4,582 | 4,294 | 5,285 |
| Total Inventory | |||||
| Total Other Current Assets | |||||
| Total Current Assets | 17,933 | 23,513 | 27,530 | 27,275 | 23,870 |
| Net Property, Plant And Equipment | 1,808 | 4,458 | 4,404 | 4,609 | 4,696 |
| Net Goodwill | |||||
| Net Intangible Assets | |||||
| Long Term Investments | |||||
| Long Term Notes Receivable | |||||
| Other Long Term Assets | |||||
| Total Assets | 20,944 | 31,159 | 36,232 | 36,573 | 32,649 |
| Accounts Payable | |||||
| Accrued Expenses | |||||
| Notes Payable / Short Term Debt | |||||
| Current Portion of Long Term Debt / Capital Leases | |||||
| Total Other Current Liabilities | |||||
| Total Current Liabilities | 10,978 | 22,795 | 24,374 | 23,163 | 20,005 |
| Long Term Debt | |||||
| Capital Lease Obligations | |||||
| Total Long Term Debt | |||||
| Total Debt | |||||
| Minority Interest | |||||
| Total Other Liabilities | |||||
| Total Funded Status | |||||
| Total Liabilities | 12,479 | 24,087 | 26,602 | 24,988 | 21,102 |
| Common Stock | |||||
| Additional Paid In Capital | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| Treasury Stock | |||||
| Unrealized Gain / Loss | |||||
| Other Equity | |||||
| Total Equity | 8,465 | 7,072 | 9,630 | 11,585 | 11,547 |
| Total Liabilities & Shareholders' Equity | 20,944 | 31,159 | 36,232 | 36,573 | 32,649 |
| Total Common Shares Outstanding |